Che Zhang’s research while affiliated with First Affiliated Hospital of China Medical University and other places

What is this page?

This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (1)

Figure 1. Pharmacoeconomic indicators of medicine (N=12). The date of 12 months was computed, and the sample size of N was 12. * P<0.05, **P<0.01 In 2016, public hospitals in 200 Chinese pilot cities abolished 15% of markups on pharmaceuticals. The proportionof medicine income to total hospital income of 2015-2019 was shown in Figure 1, it ranged from 26.66% to 25.31%. Theproportions of antibiotic revenue to medicine revenue from 2015 to 2019 were 37.53%, 29.80%, 26.41%, 20.87% and19.24%, respectively. The proportion of antibiotic revenue to western medicine revenue of 2015-2019 decreased from26.69% to 14.78%.
Figure 2. Indicators of specialized and preventive antibiotics (N=12).
Outpatient prescription and defined daily dose (DDD) of 2015-2019 (N = 12).
WHO/INRUD core drug indicators of 2015-2019 (N = 12).
Women and children’s real-world economic and drug indicators from 2015 to 2019
  • Article
  • Full-text available

October 2023

·

5 Reads

Journal of Market Access & Health Policy

Jun Zou

·

Che Zhang

·

Guohua Jia

·

Wei Lu
Download